Scholarly Index
Chin‐Lee Wu
Massachusetts General Hospital; 27,706 total citations; 399 total publications; best world rank #69
Massachusetts General Hospital
27,706Total citations
399Total publications
76H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Renal cell carcinoma treatment | Lifetime | 406 | US 226 | 98.16 |
| Prostate Cancer Treatment and Research | Lifetime | 636 | US 338 | 98.26 |
| Prostate Cancer Diagnosis and Treatment | Lifetime | 605 | US 295 | 98.13 |
| Bladder and Urothelial Cancer Treatments | Lifetime | 785 | US 342 | 97.18 |
| Renal and related cancers | Lifetime | 945 | US 453 | 96.12 |
| Molecular Biology Techniques and Applications | Lifetime | 936 | US 458 | 94.59 |
| Urologic and reproductive health conditions | Lifetime | 812 | US 394 | 95.31 |
| Urinary and Genital Oncology Studies | Lifetime | 892 | US 387 | 95.01 |
| Tuberous Sclerosis Complex Research | Lifetime | 247 | US 138 | 91.11 |
| Renal cell carcinoma treatment | 2021-2025 | 475 | US 168 | 93.16 |
| Urological Disorders and Treatments | 2021-2025 | 322 | US 88 | 92.15 |
| Bladder and Urothelial Cancer Treatments | 2021-2025 | 670 | US 195 | 92.55 |
| Renal and related cancers | 2021-2025 | 523 | US 209 | 87.20 |
| Urinary and Genital Oncology Studies | 2021-2025 | 439 | US 149 | 89.71 |
| Urologic and reproductive health conditions | 2021-2025 | 314 | US 70 | 86.08 |
| Tuberous Sclerosis Complex Research | 2021-2025 | 69 | US 30 | 84.13 |